Hepatotrophic factors reduce hepatic fibrosis in rats

Arquivos de Gastroenterologia

Volumn 47, Issue 1, 2010, Pages 79-85

  Cogliati, Bruno ^a   Pereira, Hélder De Moraes ^a   Dagli, Maria Lúcia Zaidan ^a   Parra, Osório Miguel ^a   Da Silva, José Roberto Machado Cunha ^a   Hernandez Blazquez, Francisco Javier ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Liver cirrhosis, experimental, drug therapy; Rats

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO ACID; ASPARTATE AMINOTRANSFERASE; DIMETHYLNITROSAMINE; GLUCAGON; GLUCOSE; INSULIN; SCATTER FACTOR; SODIUM CHLORIDE; TRIIODOTHYRONINE DERIVATIVE; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMETRY; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER INJURY; MORPHOMETRICS; NONHUMAN; RAT;

AMINO ACIDS; ANIMALS; COLLAGEN; FEMALE; GLUCOSE; HETEROCYCLIC COMPOUNDS; INJECTIONS, INTRAPERITONEAL; INORGANIC CHEMICALS; LIVER CIRRHOSIS, EXPERIMENTAL; NUTRITIONAL SUPPORT; RATS; RATS, WISTAR; SOLUTIONS; VITAMINS;

EID: 77953219186     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032010000100014     Document Type: Article

References (44)

1. Aherne WA, Dunnil MS. Morphometry. London: Edward Arnold; 1982.
2. Ala-Kokko L, Stenback F, Ryhanen L. Preventive effect of malotilate on dimethylnitrosamine-induced liver fibrosis in the rat. J Lab Clin Med. 1989;113:177-183 (Pubitemid 19066834)
3. Andiran F, Ayhan A, Tanyel C, Abbasoglu O, Sayek I. Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of α-Tocopherol on cirrhotic regeneration. J Surg Res. 2000;89:184-188 (Pubitemid 30196523)
4. Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD, Pawlik TM. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg. 2008;12:842-851
5. Chen JW, Chen DZ, Chen ZM. Unique pattern of fibrosing cholestatic hepatitis after liver transplantation. Hepatobiliary Pancreat Dis Int. 2002;1:33-34 (Pubitemid 36748164)
6. Cornelius CE, Bishop J, Switzer J, Rhode EA. Serum and tissue transaminase activities in domestic animals. Cornell Vet. 1959;49:116-126
7. Crawford JM. The liver and biliary tract. In: Contran RS, Kumar V, Robbins SL, editors. Pathologic basis of disease. Philadelphia: Elsevier/Saunders; 2005. p.759-808.
8. del Pozo JL. Update and actual trends on bacterial infections following liver transplantation. World J Gastroenterol. 2008;14:4977-4983
9. Fallowfield JA, Iredale J P. Targeted treatment for cirrhosis. Expert Opin Ther Targets. 2004;8:423-435
10. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331:1547-1552 (Pubitemid 24366901)
11. Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int. 2009;22:49-60.
12. Francavilla A, Zeng Q, Polimeno L, Carr BI, Sun D, Porter KA, Van Thiel DH, Starzl TE. Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology. 1994;19:210-216 (Pubitemid 24020492)
13. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol. 2003;38:38-53.
14. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669
15. Gertman PM, Madden J, Bevin AG, Smith HC. Hepatic collagen metabolism in dimethylnitrosamine induced cirrhosis in rats. Surg Forum. 1970;21:363-364
16. Goodman ZD, Ishak KG. Hepatic histopathology. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's diseases of the liver. 8th ed. Philadelphia: Lippincott/Williams & Wilkins; 1999. p.53-117.
17. Hashimoto M, Watanabe G. Functional restoration of cirrhotic liver after partial hepatectomy in the rat. Hepatogastroenterology. 2005;52:897-902. (Pubitemid 40834628)
18. Henderson NC, Forbes SJ. Hepatic fibrogenesis: from within and outwith. Toxicology. 2008;254:130-135
19. Holecek M. Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review. Nutrition. 1999;15:784-788 (Pubitemid 29461026)
20. Ikegami T, Shimada M, Imura S, Arakawa Y, Nii A, Morine Y, Kanemura H. Current concept of small-for-size grafts in living donor liver transplantation. Surg Today. 2008;38:971-982
21. Institute of Laboratory Animal Resources (ILAR). Guide for care and use of laboratory animals. Washington: National Academy Press; 1996.
22. Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 1979;11:447-455 (Pubitemid 9238595)
23. Kam I, Lynch S, Svanas G, Todo S, Polimeno L, Francavilla A, Penkrot RJ, Takaya S, Ericzon BG, Starzl TE. Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology. 1986;7:362-366 (Pubitemid 17062730)
24. Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet. 2005;44:187-200. (Pubitemid 40188940)
25. Lee MH, Ion S, Moon J-O. The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull. 2004;27:72-76
26. Li G, Ye QF, Xia SS, Chen ZS, Zeng FJ, Lin ZB, Gong NQ, Zhang WJ, Wen ZX, Sha P, Jiang J P. Acute respiratory distress syndrome after liver transplantation: etiology, prevention and management. Hepatobiliary Pancreat Dis Int. 2002;1:330-334 (Pubitemid 36748761)
27. Maclachlan NJ, Cullen JM. Liver, biliary system and exocrine pancreas. In: McGavin MD, Zachary JF, editors. Pathologic basis of veterinary disease. Philadelphia: Mosby; 2006. p.395-396
28. Neubauer K, Saile B, Ramadori G. Liver fibrosis and altered matrix synthesis. Can J Gastroenterol. 2001;15:187-193 (Pubitemid 32899123)
29. Noguchi A, Reis JMC, Dias CS, Epaminondas WA, Azevedo PSR, Brito MVH. Serum levels of aminotransferases, bilirrubins and gama-glutamyltranspeptidase after copaiba oil administration in rats. Acta Cir Bras. 2002;17:130-134
30. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008;245:194-205.
31. Parra OM, Saad WA, Ferraz-Neto JBHE, Silva RAPS, Hernandez-Blazquez FJ, Peduto L, Ferraz-Neto B. Stimulation of intact rat liver by exogenous hepatotrophic factors with additional growth of its mass. Acta Cir Bras. 1994;9:7-11.
32. Parra OM, Silva RAPS, Silva JRMC, Hernandez-Blazquez FJ, Peduto L, Saad WA, Saad Jr WA. Enhancement of liver size by stimulation of intact rat liver with exogenous hepatotrophic factors. Sao Paulo Med J. 1995;113:941-947
33. Parra OM, Hernandez-Blazquez FJ, Silva JRMC, Saad CA, Saad Jr WA. Behavior of collagen extracellular liver matrix during regenerative growth after partial hepatectomy or after stimulation by exogenous hepatotrophic factors: Study in rats. Arq Gastroenterol. 1996;33:212-216 (Pubitemid 27138087)
34. Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig Liver Dis. 2004;36:231-242 (Pubitemid 41115470)
35. Poon RTP, Fan ST. Perioperative nutritional support in liver surgery. Nutrition. 2000;16:75-76
36. Ramalho LNZ, Ramalho FS, Zucoloto S, Castro-e-Silva Jr O, Corrêa FMA, Elias Jr J, Magalhães JFG. Effect od losartan, na angiotensin II antagonist, on secondary biliary cirrhosis. Hepatogastroenterology. 2002;49:1499-1502 (Pubitemid 35277308)
37. Rockey DC. Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis. 2008;12:939-962
38. Schuppan D, Ruehl M, Somasundaram R, Han EG. Matrix as modulator of hepatic fibrinogenesis. Semin Liver Dis. 2001;21:351-372
39. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-851
40. Van Thiel DH, Gavaler JS, Kam I, Francavilla A, Polimeno L, Schade RR, Smith J,Diven W, Penkrot RJ, Starzl TE. Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology. 1987;93:1415-1419
41. Weibel ER. Stereological methods: practical methods for biological morphometry. London: Academic Press; 1989.
42. Wilasrusmee C, Sritheptawee S, Kanchanapanjapon S, Sopon P, Vanichanon C, Limpthong W, Pongchailerks P, Lertsithichai P, Wilasrusmee S, Kittur DS. Ultrastructural change in cirrhotic and noncirrhotic patients due to hepatectomy. J Hepatobiliary Pancreat Surg. 2004;11:266-271 (Pubitemid 39264130)
43. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199-210.
44. Zhang ZT, Jiang P, Wang Y, Li JS, Xue JG, Zhou YZ, Yuan Z. Effects of hepatotrophic factors on the liver after portacaval shunt in rats with portal hypertension. Chin Med J. 2006;119:1727-1733 (Pubitemid 44697238)